ReGear Life Sciences has secured additional funding for its ReBound deep tissue heating pain management device, according to a Medcity News report.
The pain device, marketed for a wide range of conditions including arthritis, carpal tunnel syndrome and tendinitis, delivers an electromagnetic field deep into tissues to generate therapeutic heating up to 4 centimeters below the skin's surface. Equity for the company's four-pound ReBound device has increased from $500,000 to $850,000 since July.
ReBound, which the company says decreases pain while increasing mobility, comes with several different "therapy garments" that contain heating coils and fit over various body parts.
Opioids Increasingly Prescribed for Chronic Abdominal Pain, Study Says
Soldiers Need Greater Emphasis on Pain Management Treatment, Physician Says
The pain device, marketed for a wide range of conditions including arthritis, carpal tunnel syndrome and tendinitis, delivers an electromagnetic field deep into tissues to generate therapeutic heating up to 4 centimeters below the skin's surface. Equity for the company's four-pound ReBound device has increased from $500,000 to $850,000 since July.
ReBound, which the company says decreases pain while increasing mobility, comes with several different "therapy garments" that contain heating coils and fit over various body parts.
Related Articles on Pain Management:
West Virginia Gov. Signs Bill to Curb "Doctor Shopping"Opioids Increasingly Prescribed for Chronic Abdominal Pain, Study Says
Soldiers Need Greater Emphasis on Pain Management Treatment, Physician Says